{
    "eid": "2-s2.0-85033389491",
    "title": "HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: Implications for improved diagnostic option in an era of affordable DAAs",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "General Agricultural and Biological Sciences",
            "@code": "1100"
        },
        {
            "$": "General Biochemistry",
            "@code": "1300"
        },
        {
            "$": "General Neuroscience",
            "@code": "2800"
        }
    ],
    "keywords": [
        "Active HCV infection",
        "HCV Ag",
        "HCV RNA",
        "Hepatitis C virus"
    ],
    "authors": [
        "Rujipat Wasitthankasem"
    ],
    "citedby-count": 23,
    "ref-count": 40,
    "ref-list": [
        "Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection",
        "New direct-acting antivirals for patients with chronic HCV infection: can we monitor treatment using an HCV core antigen assay?",
        "Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication",
        "Non-invasive evaluation of liver fibrosis using transient elastography",
        "Global control of hepatitis C virus: A comprehensive strategy to control HCV infection must include a vaccine",
        "Epidemiology of viral hepatitis and hepatocellular carcinoma",
        "Clinical usefulness of HCV core antigen assay for the management of patients with chronic hepatitis C",
        "Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: A systematic review and meta-analysis",
        "Efficacy of Ledipasvir and Sofosbuvir, with or Without Ribavirin, for 12 Weeks in Patients with HCV Genotype 3 or 6 Infection",
        "Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009",
        "Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance",
        "Global epidemiology and genotype distribution of the hepatitis C virus infection",
        "Epidemiology and natural history of HCV infection",
        "Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection",
        "Treatment of acute hepatitis C with interferon alfa-2b",
        "Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting",
        "Can hepatitis C virus antigen testing replace ribonucleic acid polymearse chain reaction analysis for detecting hepatitis C virus? A systematic review",
        "Is hepatitis C virus core antigen an adequate marker for community screening?",
        "HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis",
        "Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay",
        "Prevalence of hepatitis B and hepatitis C virus infections in france in 2004: Social factors are important predictors after adjusting for known risk factors",
        "Performance of ARCHITECT HCV core antigen test with specimens from US plasma donors and injecting drug users",
        "Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades",
        "The role of hepatitis c virus core antigen testing in the era of direct acting antiviral therapies: What we can learn from the protease inhibitors",
        "Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples",
        "The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide",
        "HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients",
        "Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification",
        "International survey on NAT testing of blood donations: Expanding implementation and yield from 1999 to 2009",
        "Variable Ratio of Hepatitis C Virus RNA to Viral Core Antigen in Patient Sera",
        "A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus",
        "Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection",
        "The correlation between hepatitis C core antigen and hepatitis c virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism",
        "Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment",
        "Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis",
        "Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence",
        "Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia",
        "Sofosbuvir and Ribavirin in HCV genotypes 2 and 3"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Thailand Research Fund"
    ]
}